Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03020966 · ClinicalTrials.gov registry record · Phase 4

IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty

A Phase 4 study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
Phase 4
Development phase
154
Enrollment target
1
Study location

NCT03020966 is a Phase 4 study of Pain, Postoperative and Opioid Use that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 154 participants, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03020966, a Phase 4 study of Pain, Postoperative and Opioid Use, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
Phase 4
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine how well two different methods of administrating Tylenol reduce pain and improve patient satisfaction after total hip replacement (THR) surgery. The methods of administration are orally, via a pill that is to be swallowed, and intravenously. Our aim is to determine whether oral or intravenous administration of Tylenol will reduce opioid consumption and opioid-related side effects after THR.

Interventions

  • DRUG Acetaminophen

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2017-02-16
Est. Completion 2019-06-16
Phase Phase 4

What the Registry Record Tells You About NCT03020966

The ClinicalTrials.gov registry entry for NCT03020966 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (43% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Acetaminophen is the first listed.

NCT03020966 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03020966 about?

NCT03020966 is a clinical study titled "IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty". The purpose of this study is to determine how well two different methods of administrating Tylenol reduce pain and improve patient satisfaction after total hip replacement (THR) surgery. The methods of administration are orally, via a pill that is to be swallowed, and intravenously. Our aim is to de...

What is the current status of trial NCT03020966?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2017-02-16. Estimated completion is 2019-06-16.

What conditions does trial NCT03020966 study?

This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use.

What interventions are being tested in trial NCT03020966?

The interventions under investigation include: Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT03020966?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03020966 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.